506 related articles for article (PubMed ID: 15562137)
1. Implications of pharmaceutical industry funding on clinical research.
Lexchin JR
Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137
[TBL] [Abstract][Full Text] [Related]
2. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases?
Liyanage SS; Raina Macintyre C
Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128
[TBL] [Abstract][Full Text] [Related]
3. Independent medical research.
van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
[No Abstract] [Full Text] [Related]
4. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
Campbell MJ
Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
[No Abstract] [Full Text] [Related]
5. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
Amsden GW
Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
[No Abstract] [Full Text] [Related]
6. Evaluating solutions to sponsorship bias.
Doucet M; Sismondo S
J Med Ethics; 2008 Aug; 34(8):627-30. PubMed ID: 18667655
[TBL] [Abstract][Full Text] [Related]
7. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
[TBL] [Abstract][Full Text] [Related]
8. Justice in the application of science: beyond fair benefits.
London AJ
Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976
[No Abstract] [Full Text] [Related]
9. [Conflicts of interest--an evidence-based approach].
Slørdal L; Eggen AE; Rygnestad T
Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1358-60. PubMed ID: 22717864
[No Abstract] [Full Text] [Related]
10. Achieving greater independence from commercial influence in research.
Lexchin J; Bero LA; Davis C; Gagnon MA
BMJ; 2021 Mar; 372():n370. PubMed ID: 33687982
[No Abstract] [Full Text] [Related]
11. Industry funded clinical trials: bias and quality.
Del Parigi A
Curr Med Res Opin; 2012 Jan; 28(1):23-5. PubMed ID: 22103762
[TBL] [Abstract][Full Text] [Related]
12. Response to open peer commentaries on "How to do research fairly in an unjust world".
Ballantyne AJ
Am J Bioeth; 2010 Jun; 10(6):W4-6. PubMed ID: 20526959
[No Abstract] [Full Text] [Related]
13. Medicine and the pharmaceutical industry.
Baxter P
Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
[No Abstract] [Full Text] [Related]
14. The perverse consequences of a proposed global tax on research.
MacDonald C; Walton N
Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
[No Abstract] [Full Text] [Related]
15. In the dark: drug companies should be forced to publish all the results of clinical trials.
Chalmers I
New Sci; 2004 Mar 6-12; 181(2437):19. PubMed ID: 15139350
[No Abstract] [Full Text] [Related]
16. Commentary: Professional responsibilities.
Jacobs A
Pharm Stat; 2011; 10(1):82. PubMed ID: 21275039
[No Abstract] [Full Text] [Related]
17. Industry sponsorship and authorship of clinical trials over 20 years.
Buchkowsky SS; Jewesson PJ
Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
[TBL] [Abstract][Full Text] [Related]
18. Research dishonesty and conflict of interest.
Frizelle F
N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
[No Abstract] [Full Text] [Related]
19. Medicine in the Noise Age: what can we believe?
Angell M
Account Res; 2001; 8(3):189-95. PubMed ID: 12481786
[No Abstract] [Full Text] [Related]
20. Biased articles.
Friedman JH
Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
